SAMSUNG BIOLOGICS CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 781,000 KRW | 0.00% |
|
-1.26% | +2.76% |
| May. 06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
| Apr. 25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
Quotes 5-day view
End-of-day quote Korea S.E.| 2024-05-08 | 2024-05-09 | 2024-05-10 | 2024-05-13 | 2024-05-14 | |
|---|---|---|---|---|---|
| Last | 791000 ₩ | 781000 ₩ | 787000 ₩ | 781000 ₩ | 781000 ₩ |
| Volume | 82 414 | 82 989 | 65 984 | 35 239 | 28 625 |
| Change | +0.76% | -1.26% | +0.77% | -0.76% | 0.00% |
| Opening | 795,000.00 | 796,000.00 | 789,000.00 | 791,000.00 | 783,000.00 |
| High | 803,000.00 | 796,000.00 | 794,000.00 | 794,000.00 | 789,000.00 |
| Low | 790,000.00 | 779,000.00 | 783,000.00 | 780,000.00 | 779,000.00 |
Performance
| 1 week | -1.26% | ||
| 1 month | -1.51% | ||
| 3 months | -4.87% | ||
| 6 months | +6.69% | ||
| Current year | +2.76% | ||
| 1 year | -1.01% | ||
| 3 years | -17.62% | ||
| 5 years | +151.94% |
Volumes
marketsDaily volume
28 625
Avg. Volume 20 sessions
62 895
Avg. Volume 20 sessions KRW
49 120 995 000.00
Avg. Volume 20 sessions USD
36 349 536.30
Record volume 1
8 089 601
Record volume 2
7 156 671
Record volume 3
3 037 569
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (KRW)
55 050 438 486 487
Capitalization (USD)
40 737 324 480
Net sales (KRW)
3 695
Net sales (USD)
3
Number of employees
4 284
Sales / Employee (KRW)
1
Sales / Employee (USD)
0
Free-Float
25.25 %
Free-Float capitalization (KRW)
13 902 771 128 765
Free-Float capitalization (USD)
10 288 050 635
Average Daily Capital Traded
0.09%
Highs and lows
1 week
779 000.00
794 000.00
1 month
768 000.00805 000.00
Current year
739 000.00880 000.00
1 year
668 000.00880 000.00
3 years
668 000.001 000 000.00
5 years
241 500.001 000 000.00
10 years
125 500.001 000 000.00
Indicators
Moving average 5 days
784 200.00
Moving average 20 days
783 300.00
Moving average 50 days
805 560.00
Moving average 100 days
793 480.00
Price spread / (MMA5)
+0.41%
Price spread / (MMA20)
+0.29%
Price spread / (MMA50)
+3.14%
Price spread / (MMA100)
+1.60%
STIM
RSI 9 days
45.97
RSI 14 days
45.13
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| 0.00% | -1.26% | +2.76% | -1.01% | 40.74B | ||
| +1.24% | +1.13% | -1.26% | -8.04% | 89.46B | ||
| +3.72% | +7.10% | -9.06% | -24.55% | 33.03B | ||
| +1.91% | +1.07% | +55.32% | +41.87% | 24.68B | ||
| +0.94% | -1.75% | -16.61% | -15.53% | 15.12B | ||
| 0.00% | +6.62% | -9.14% | -13.82% | 12.81B | ||
| -1.83% | -3.82% | -12.11% | -7.28% | 11.79B | ||
| -2.02% | -5.41% | -43.61% | -31.53% | 11.64B | ||
| +1.55% | +1.48% | +7.79% | +21.13% | 8.9B | ||
| -0.13% | -1.38% | -7.72% | -1.50% | 8.22B | ||
| +1.72% | -0.24% | -6.67% | +2.97% | 6.94B | ||
| -1.77% | -0.40% | -3.39% | +16.53% | 6.93B | ||
| -1.07% | -0.27% | -7.12% | +14.66% | 6.86B | ||
| +6.14% | +0.23% | +77.16% | +290.38% | 6.78B | ||
| +3.37% | +9.16% | -34.13% | -10.23% | 6.33B | ||
| +3.52% | +8.19% | -25.76% | +101.95% | 5.42B | ||
| Average | +1.08% | +1.11% | -2.10% | +23.50% | ||
| Weighted average by Cap. | +1.14% | +1.47% | +0.34% | +4.95% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +2.76% | ||
| 2023 | -7.43% | ||
| 2022 | -9.08% | ||
| 2021 | +9.32% | ||
| 2020 | +90.76% | ||
| 2019 | +12.03% | ||
| 2018 | +4.18% | ||
| 2017 | +145.70% | ||
| 2016 | +4.86% |
- Stock Market
- Equities
- A207940 Stock
- Quotes Samsung Biologics Co.,Ltd.